Helicobacter pylori infection and coronary heart disease in Japanese patients

H Osawa1, M Kawakami, M Fujii

  • 1Division of Integrated Medicine, Omiya Medical Center, Jichi Medical School, Omiya Cityi, Japan.

Cardiology
|June 1, 2001
PubMed

Insights

Helicobacter pylori infection is an independent risk factor for coronary heart disease (CHD) in Japanese patients, particularly those without diabetes or smoking history. This finding suggests a clinically relevant association between H. pylori and CHD.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • The link between Helicobacter pylori infection and coronary heart disease (CHD) remains inconclusive despite previous studies.
  • Investigating this association in Japanese populations is crucial for understanding global health implications.

Purpose of the Study:

  • To determine if Helicobacter pylori infection is associated with coronary heart disease (CHD) in Japanese patients.
  • To evaluate H. pylori as an independent risk factor for CHD.

Main Methods:

  • A study of 304 patients undergoing coronary arteriography, assessing H. pylori infection serologically.
  • Coronary stenosis was categorized into no significant stenosis, single-vessel, and multi-vessel.
  • Serum pepsinogen I-II ratio was used to assess gastric atrophy.

Main Results:

  • H. pylori seropositivity was significantly higher in CHD patients (67%) versus controls (50%).
  • The odds ratio for CHD associated with H. pylori infection was 1.35 after adjusting for common risk factors.
  • The association was stronger in patients without a history of diabetes or smoking.

Conclusions:

  • Helicobacter pylori infection is an independent risk factor for coronary heart disease in Japanese patients.
  • The findings suggest a clinically relevant association between H. pylori and CHD, especially in specific subgroups.
  • Further research may elucidate the mechanisms underlying this cardiovascular link.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...